{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:59Z","timestamp":1772165819448,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06966-2","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T03:23:01Z","timestamp":1747884181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential risk factors for methamphetamine use among inmates in a Japanese prison"],"prefix":"10.1186","volume":"25","author":[{"given":"Masahiko","family":"Takaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoto","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"6966_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","volume":"80","author":"S Potvin","year":"2018","unstructured":"Potvin S, Pelletier J, Grot S, Hebert C, Barr AM, Lecomte T. Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis. Addict Behav. 2018;80:154\u201360.","journal-title":"Addict Behav"},{"key":"6966_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/SAR.S431273","volume":"15","author":"JR Yates","year":"2024","unstructured":"Yates JR. Pharmacological treatments for methamphetamine use disorder: current status and future targets. Subst Abuse Rehabil. 2024;15:125\u201361.","journal-title":"Subst Abuse Rehabil"},{"key":"6966_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jsat.2019.09.005","volume":"109","author":"AM Stuart","year":"2020","unstructured":"Stuart AM, Baker AL, Denham AMJ, Lee NK, Hall A, Oldmeadow C, et al. Psychological treatment for methamphetamine use and associated psychiatric symptom outcomes: A systematic review. J Subst Abuse Treat. 2020;109:61\u201379.","journal-title":"J Subst Abuse Treat"},{"key":"6966_CR4","doi-asserted-by":"publisher","first-page":"629315","DOI":"10.3389\/fpsyt.2021.629315","volume":"12","author":"Y Sekiguchi","year":"2021","unstructured":"Sekiguchi Y, Okada T, Okumura Y. Treatment response distinguishes persistent type of methamphetamine psychosis from schizophrenia spectrum disorder among inmates at Japanese medical prison. Front Psychiatry. 2021;12:629315.","journal-title":"Front Psychiatry"},{"key":"6966_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11011-014-9496-5","volume":"29","author":"T Akindipe","year":"2014","unstructured":"Akindipe T, Wilson D, Stein DJ. Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors. Metab Brain Dis. 2014;29:351\u20137.","journal-title":"Metab Brain Dis"},{"key":"6966_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S0033291703008353","volume":"33","author":"CK Chen","year":"2003","unstructured":"Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33:1407\u201314.","journal-title":"Psychol Med"},{"key":"6966_CR7","first-page":"1","volume":"19","author":"S Karabulut","year":"2024","unstructured":"Karabulut S. Factors associated with psychotic and depressive symptoms in methamphetamine users. Iran J Psychiatry. 2024;19:1\u201310.","journal-title":"Iran J Psychiatry"},{"key":"6966_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.apnu.2024.07.007","volume":"52","author":"H Hancer Tok","year":"2024","unstructured":"Hancer Tok H, Tokur Kesgin M. Reasons for using methamphetamine: systematic review. Arch Psychiatr Nurs. 2024;52:147\u201354.","journal-title":"Arch Psychiatr Nurs"},{"key":"6966_CR9","doi-asserted-by":"publisher","first-page":"109145","DOI":"10.1016\/j.drugalcdep.2021.109145","volume":"229","author":"ER Hansen","year":"2021","unstructured":"Hansen ER, Carvalho S, McDonald M, Havens JR. A qualitative examination of recent increases in methamphetamine use in a cohort of rural people who use drugs. Drug Alcohol Depend. 2021;229:109145.","journal-title":"Drug Alcohol Depend"},{"key":"6966_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.addbeh.2006.03.017","volume":"32","author":"ML Brecht","year":"2007","unstructured":"Brecht ML, Greenwell L, Anglin MD. Substance use pathways to methamphetamine use among treated users. Addict Behav. 2007;32:24\u201338.","journal-title":"Addict Behav"},{"key":"6966_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/10550490701756294","volume":"17","author":"SJ Semple","year":"2008","unstructured":"Semple SJ, Zians J, Strathdee SA, Patterson TL. Methamphetamine-using felons: psychosocial and behavioral characteristics. Am J Addict. 2008;17:28\u201335.","journal-title":"Am J Addict"},{"key":"6966_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1465-3362.2009.00146.x","volume":"29","author":"SG Sherman","year":"2010","unstructured":"Sherman SG, Sutcliffe CG, Srirojn B, German D, Thomson N, Aramrattana A, Celentano DD. Predictors and consequences of incarceration among a sample of young Thai methamphetamine users. Drug Alcohol Rev. 2010;29:399\u2013405.","journal-title":"Drug Alcohol Rev"},{"key":"6966_CR13","doi-asserted-by":"publisher","first-page":"105699","DOI":"10.1016\/j.neubiorev.2024.105699","volume":"162","author":"D Oliver","year":"2024","unstructured":"Oliver D, Chesney E, Cullen AE, Davies C, Englund A, Gifford G, et al. Exploring causal mechanisms of psychosis risk. Neurosci Biobehav Rev. 2024;162:105699.","journal-title":"Neurosci Biobehav Rev"},{"key":"6966_CR14","first-page":"284","volume":"27","author":"H Suwaki","year":"1992","unstructured":"Suwaki H, Yamasaki M, Horii S, Watanabe T, Kazunaga H, Fujimoto A. A study of longitudinal patterns of substance abuse with special reference to multiple use problems. Arukoru Kenkyuto Yakubutsu Ison. 1992;27:284\u201396.","journal-title":"Arukoru Kenkyuto Yakubutsu Ison"},{"key":"6966_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12888-021-03169-3","volume":"21","author":"LA Basedow","year":"2021","unstructured":"Basedow LA, Kuitunen-Paul S, Wiedmann MF, Ehrlich S, Roessner V, Golub Y. Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study. BMC Psychiatry. 2021;21:166.","journal-title":"BMC Psychiatry"},{"key":"6966_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/ajad.13262","volume":"31","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto T, Kimura T, Tamakoshi A, Matsumoto T. Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross-sectional study in Japan. Am J Addict. 2022;31:134\u201341.","journal-title":"Am J Addict"},{"key":"6966_CR17","doi-asserted-by":"publisher","first-page":"1041762","DOI":"10.3389\/fpsyt.2022.1041762","volume":"13","author":"U Bonnet","year":"2022","unstructured":"Bonnet U, Specka M, Kanti AK, Scherbaum N. Differences between users\u2019 and addiction medicine experts\u2019 harm and benefit assessments of licit and illicit psychoactive drugs: input for psychoeducation and legalization\/restriction debates. Front Psychiatry. 2022;13:1041762.","journal-title":"Front Psychiatry"},{"key":"6966_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1080\/10826084.2023.2184207","volume":"58","author":"K Ivey","year":"2023","unstructured":"Ivey K, Bernstein KT, Kirkcaldy RD, Kissinger P, Edwards OW, Sanchez T, et al. Chemsex drug use among a National sample of sexually active men who have sex with men, - American Men\u2019s internet survey, 2017\u20132020. Subst Use Misuse. 2023;58:728\u201334.","journal-title":"Subst Use Misuse"},{"key":"6966_CR19","doi-asserted-by":"publisher","first-page":"1366216","DOI":"10.3389\/fnins.2024.1366216","volume":"18","author":"K Braunscheidel","year":"2024","unstructured":"Braunscheidel K, Okas M, Woodward JJ. Toluene alters the intrinsic excitability and excitatory synaptic transmission of basolateral amygdala neurons. Front Neurosci. 2024;18:1366216.","journal-title":"Front Neurosci"},{"key":"6966_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/npp.2017.117","volume":"43","author":"WN Wayman","year":"2018","unstructured":"Wayman WN, Woodward JJ. Exposure to the abused inhalant toluene alters medial prefrontal cortex physiology. Neuropsychopharmacology. 2018;43:912\u201324.","journal-title":"Neuropsychopharmacology"},{"key":"6966_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.5811\/westjem.2019.7.41661","volume":"20","author":"M Ren","year":"2019","unstructured":"Ren M, Lotfipour S. Nicotine gateway effects on adolescent substance use. West J Emerg Med. 2019;20:696\u2013709.","journal-title":"West J Emerg Med"},{"key":"6966_CR22","doi-asserted-by":"publisher","first-page":"1445303","DOI":"10.3389\/fphar.2024.1445303","volume":"15","author":"D Carreno","year":"2024","unstructured":"Carreno D, Facundo A, Cardenas A, Lotfipour S. Sub-chronic nicotine exposure influences methamphetamine self-administration and dopamine overflow in a sex-and genotype-dependent manner in humanized CHRNA6 3\u2019-UTR SNP (rs2304297) adolescent rats. Front Pharmacol. 2024;15:1445303.","journal-title":"Front Pharmacol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06966-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:03:22Z","timestamp":1747926202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06966-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6966"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06966-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5504895\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study adhered to the Declaration of Helsinki and was approved by Ethics Review Committee of Correctional Medicine Academic Research Council, established by the Correction Bureau, Ministry of Justice of Japan. The requirement for informed consent was waived by the same committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"519"}}